Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)

ClinicalTrials.gov ID: NCT01908829

Public ClinicalTrials.gov record NCT01908829. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms

Study identification

NCT ID
NCT01908829
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Europe Ltd.
Industry
Enrollment
2,174 participants

Conditions and interventions

Interventions

  • mirabegron 25 mg Drug
  • mirabegron 50 mg Drug
  • solifenacin 5 mg Drug
  • solifenacin 10 mg Drug
  • mirabegron 25 mg matching placebo Drug
  • mirabegron 50 mg matching placebo Drug
  • solifenacin 5 mg matching placebo Drug
  • solifenacin 10 mg matching placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 9, 2013
Primary completion
Nov 23, 2014
Completion
Nov 24, 2014
Last update posted
Oct 30, 2024

2013 – 2014

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
34
Facility City State ZIP Site status
Genova Clinical Research Tucson Arizona 85704
Associated Pharmaceutical Research Center, Inc. Buena Park California 90620
The American Institute of Research Los Angeles California 90017
Bayview Research Group Valley Village California 91607
Meridien Research Brooksville Florida 33016
Innovative Research of West FL Clearwater Florida 33756
Best Quality Research Inc. Hialeah Florida 33016
Palmetto Professional Research Hialeah Florida 33016
Urology Center of Central Florida Kissimmee Florida 34741
Meridien Research Tampa Florida 33606
Stedman Clinical Trials Tampa Florida 33613
Private Practice West Palm Beach Florida 33407
Meridian Clinical Research, LLC Savannah Georgia 31406
Herman Clinical Research Suwanee Georgia 30024
North Idaho Urology Coeur d'Alene Idaho 83814
First Urology, PSC Jeffersonville Indiana 47130
Deaconess Gateway Health Center Newburgh Indiana 47630
MedStar Health Research Institute Hyattsville Maryland 20782
Bay State Clinical Trials, Inc. Watertown Massachusetts 02472
Beyer Research Kalamazoo Michigan 49009
Quality Clinical Research Omaha Nebraska 68114
Albuquerque Clinical Trials, Inc. Albuquerque New Mexico 87102
Brooklyn Urology Research Group Brooklyn New York 11215
Advanced Urology Centers of New York Garden City New York 11530
Premier Medical Group of the Hudson Valley PC Kingston New York 12401
Premier Medical Group of the Hudson Valley PC Poughkeepsie New York 12601
PMG Research of Raleigh, dba PMG Research of Cary Cary North Carolina 27518
Alliance Urology Specialists Greensboro North Carolina 27403
Wake Research Associates LLC Raleigh North Carolina 27612
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103
The Urology Group Cincinnati Ohio 45212
Providence Health Partners Dayton Ohio 45439
The Clinical Trial Center Jenkintown Pennsylvania 19046
Health Concepts Rapid City South Dakota 57702
Jean Brown Research Salt Lake City Utah 84124
Alexandria Clinical Research Alexandria Virginia 22304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 183 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01908829, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 30, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01908829 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →